HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multiple Neoplasms Simultaneously Diagnosed by Complementary Triple-Tracer PET/CT and 123I-MIBG Scintigraphy.

Abstract
A 51-year-old woman with recurrent paragangliomas and catecholamine hypersecretion underwent F-FDG PET/CT for localization and evaluation of extent of disease. This revealed multiple F-FDG avid tumors with localization pattern suggesting multiple primary neoplasms of different origin rather than disseminated paraganglioma. Three additional nuclear medicine investigations were performed (F-DOPA PET/CT, Ga-DOTATOC PET/CT and I-MIBG scintigraphy) to further characterize tumor biology, guide diagnostic workup, and decide treatment strategy. Biopsies showed benign paraganglioma, mucinous adenocarcinoma of the cecum, renal cell carcinoma, and thyroid colloid nodule. Treatment strategy was based on tumor biology determined by the various PET and SPECT tracers used.
AuthorsEsben Søndergaard, Andreas Ebbehoj, Per Løgstrup Poulsen, Lars Christian Gormsen
JournalClinical nuclear medicine (Clin Nucl Med) Vol. 42 Issue 1 Pg. e61-e66 (Jan 2017) ISSN: 1536-0229 [Electronic] United States
PMID27824319 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Ga(III)-DOTATOC
  • Organometallic Compounds
  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18
  • fluorodopa F 18
  • 3-Iodobenzylguanidine
  • Dihydroxyphenylalanine
  • Octreotide
Topics
  • 3-Iodobenzylguanidine
  • Dihydroxyphenylalanine (analogs & derivatives)
  • Female
  • Fluorodeoxyglucose F18
  • Humans
  • Middle Aged
  • Neoplasms, Multiple Primary (diagnostic imaging)
  • Octreotide (analogs & derivatives)
  • Organometallic Compounds
  • Positron Emission Tomography Computed Tomography
  • Radiopharmaceuticals

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: